{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:33:24Z","timestamp":1770035604760,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study assessed the clinical risk factors for periorbital dermatitis (PD) after using dorzolamide\/timolol eye drops in a total of 1282 glaucoma patients. Both the PD(+) group and the PD(\u2212) group were evaluated using clinical data such as age, sex, dosing duration, presence of benzalkonium chloride (BAK) in the formulation, ocular surgery history (e.g. cataract or glaucoma operations), height, weight, personal history of systemic hypertension, smoking, alcohol consumption, intraocular pressure, best-corrected visual acuity (BCVA), central corneal thickness, axial length, and visual field index (VFI). Univariate analyses showed that shorter dosing duration, higher rate of BAK-included cases, worse BCVA, worse VFI, more systemic hypertension history, and more ocular surgery history were more associated with the PD(+) group than the PD(\u2212) group. The BAK(\u2212) group showed a lower PD rate than the BAK-included group, which was supported by the Kaplan\u2013Meier analysis (log-rank test, p\u2009=\u20090.0014). Multivariate analyses revealed that the probability of PD increased by 8 times if they had a history of ocular surgery and increased by 2.3% when the VFI decreased by 1% (Cox\u2019s hazard regression test, p\u2009&lt;\u20090.001). Therefore, a preservative-free dorzolamide\/timolol can benefit the subjects for those who had ocular surgery or who have worse VFI.<\/jats:p>","DOI":"10.1038\/s41598-021-97565-0","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:06:24Z","timestamp":1631181984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk factors for periorbital dermatitis in patients using dorzolamide\/timolol eye drops"],"prefix":"10.1038","volume":"11","author":[{"given":"Myungjin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoju","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungsoo","family":"Rho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"issue":"7","key":"97565_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/bjo.2009.174607","volume":"95","author":"S Morris","year":"2011","unstructured":"Morris, S., Barlow, R., Selva, D. & Malhotra, R. Allergic contact dermatitis: A case series and review for the ophthalmologist. Br. J. Ophthalmol. 95(7), 903\u2013908. https:\/\/doi.org\/10.1136\/bjo.2009.174607 (2011).","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"97565_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/bjophthalmol-2013-304197","volume":"98","author":"L Landeck","year":"2014","unstructured":"Landeck, L., John, S. M. & Geier, J. Topical ophthalmic agents as allergens in periorbital dermatitis. Br. J. Ophthalmol. 98(2), 259\u2013262. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304197 (2014).","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"97565_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0536.1991.tb01806.x","volume":"25","author":"N Cameli","year":"1991","unstructured":"Cameli, N., Vicenzi, C., Tosti, A. & Tosti, A. Allergic contact dermtitis due to timolol in eyedrops. Contact Dermatitis 25(2), 129\u2013130. https:\/\/doi.org\/10.1111\/j.1600-0536.1991.tb01806.x (1991).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"97565_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-0536.1998.tb05905.x","volume":"39","author":"K Aalto-Korte","year":"1998","unstructured":"Aalto-Korte, K. Contact allergy to dorzolamide eyedrops. Contact Dermatitis 39(4), 206. https:\/\/doi.org\/10.1111\/j.1600-0536.1998.tb05905.x (1998).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"97565_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ijd.12880","volume":"55","author":"P Kasemsarn","year":"2016","unstructured":"Kasemsarn, P., Iamphonrat, T. & Boonchai, W. B. Risk factors and common contact allergens in facial allergic contact dermatitis patients. Int. J. Dermatol. 55(4), 417\u2013424. https:\/\/doi.org\/10.1111\/ijd.12880 (2016).","journal-title":"Int. J. Dermatol."},{"issue":"4","key":"97565_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/jop.2018.0134","volume":"35","author":"C Wolfram","year":"2019","unstructured":"Wolfram, C., Stahlberg, E. & Pfeiffer, N. Patient-reported nonadherence with glaucoma therapy. J. Ocul. Pharmacol. Ther. 35(4), 223\u2013228. https:\/\/doi.org\/10.1089\/jop.2018.0134 (2019).","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"11","key":"97565_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/bjo.77.11.740","volume":"77","author":"BF O\u2019Donnell","year":"1993","unstructured":"O\u2019Donnell, B. F. & Foulds, I. S. Contact allergic dermatitis and contact urticaria due to topical ophthalmic preparations. Br. J. Ophthalmol. 77(11), 740\u2013741. https:\/\/doi.org\/10.1136\/bjo.77.11.740 (1993).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"97565_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0536.2007.01126.x","volume":"57","author":"PR Chaudhari","year":"2007","unstructured":"Chaudhari, P. R. & Maibach, H. I. Allergic contact dermatitis from ophthalmics: 2007. Contact Dermatitis 57(1), 11\u201313. https:\/\/doi.org\/10.1111\/j.1600-0536.2007.01126.x (2007).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"97565_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/ajcd.2001.25129","volume":"12","author":"MR Holdiness","year":"2001","unstructured":"Holdiness, M. R. Contact dermatitis to topical drugs for glaucoma. Am. J. Contact Dermat. 12(4), 217\u2013219. https:\/\/doi.org\/10.1053\/ajcd.2001.25129 (2001).","journal-title":"Am. J. Contact Dermat."},{"key":"97565_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2340\/00015555-0162","volume":"86","author":"U Jappe","year":"2006","unstructured":"Jappe, U., Uter, W., Menezes de Padua, C., Herbst, R. A. & Schnuch, A. Allergic contact dermatitis due to beta-blockers in eye drops: A retrospective analysis of multicentre surveillance data 1993\u20132004. Acta. Derm. Venereol. 86, 509\u2013514 (2006).","journal-title":"Acta. Derm. Venereol."},{"key":"97565_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/OPTH.S74555","volume":"9","author":"SJ Lee","year":"2015","unstructured":"Lee, S. J. & Kim, M. Allergic contact dermatitis caused by dorzolamide eyedrops. Clin. Ophthalmol. 9, 575\u2013577. https:\/\/doi.org\/10.2147\/OPTH.S74555 (2015).","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"97565_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1600-0536.2006.00927.x","volume":"55","author":"KA Amin","year":"2006","unstructured":"Amin, K. A. & Belsito, D. V. The aetiology of eyelid dermatitis: A 10-year retrospective analysis. Contact Dermatitis 55(5), 280\u2013285. https:\/\/doi.org\/10.1111\/j.1600-0536.2006.00927.x (2006).","journal-title":"Contact Dermatitis"},{"issue":"6","key":"97565_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/bjophthalmol-2016-308505","volume":"101","author":"CY Kim","year":"2017","unstructured":"Kim, C. Y. et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br. J. Ophthalmol. 101(6), 801\u2013807. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308505 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"97565_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1136\/bjo.86.4.378","volume":"86","author":"YM Delaney","year":"2002","unstructured":"Delaney, Y. M. et al. Periorbital dermatitis as a side effect of topical dorzolamide. Br. J. Ophthalmol. 86, 378\u2013380 (2002).","journal-title":"Br. J. Ophthalmol."},{"key":"97565_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/DER.0000000000000220","volume":"27","author":"VA Deleo","year":"2016","unstructured":"Deleo, V. A. et al. The association of race\/ethnicity and patch test results: North American contact dermatitis group, 1998\u20132006. Dermatitis 27, 288\u2013292 (2016).","journal-title":"Dermatitis"},{"issue":"2","key":"97565_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo, C. A. et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30(2), 239\u2013245. https:\/\/doi.org\/10.1038\/clpt.1981.154 (1981).","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"97565_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/cod.12157","volume":"70","author":"L Landeck","year":"2014","unstructured":"Landeck, L., John, S. M. & Geier, J. Periorbital dermatitis in 4779 patients\u2014Patch test results during a 10-year period. Contact Dermatitis 70(4), 205\u2013212. https:\/\/doi.org\/10.1111\/cod.12157 (2014).","journal-title":"Contact Dermatitis"},{"key":"97565_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.0105-1873.2004.00334.x","volume":"51","author":"RA Herbst","year":"2004","unstructured":"Herbst, R. A., Uter, W., Pirker, C., Geier, J. & Frosch, P. J. Allergic and non-allergic periorbital dermatitis: Patch test results of the information network of the Departments of Dermatology during a 5-year period. Contact Dermatitis 51, 13\u201319 (2004).","journal-title":"Contact Dermatitis"},{"key":"97565_CR19","first-page":"1034","volume":"142","author":"AGC De Groot","year":"1998","unstructured":"De Groot, A. G. C. & Bruynzell, D. P. Contact allergy to eyedrops containing beta-blockers. Nederslands Tijdschr. Geneesk. 142, 1034\u20131036 (1998).","journal-title":"Nederslands Tijdschr. Geneesk."},{"issue":"2","key":"97565_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0536.1995.tb00530.x","volume":"33","author":"P Koch","year":"1995","unstructured":"Koch, P. Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers. Contact Dermatitis 33(2), 140\u2013141. https:\/\/doi.org\/10.1111\/j.1600-0536.1995.tb00530.x (1995).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"97565_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1600-0536.1990.tb05070.x","volume":"23","author":"G Gailhoper","year":"1990","unstructured":"Gailhoper, G. & Ludvan, M. Medicaments\u2018Beta-blockers\u2019: Sensitizers in periorbital allergic contact dermatitis. Contact Dermatitis 23(4), 262\u2013262. https:\/\/doi.org\/10.1111\/j.1600-0536.1990.tb05070.x (1990).","journal-title":"Contact Dermatitis"},{"issue":"4","key":"97565_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/cod.12435","volume":"73","author":"MM Otero-Rivas","year":"2015","unstructured":"Otero-Rivas, M. M., Ruiz-Gonz\u00e1lez, I., Valladares-Narganes, L. M., Delgado-Vicente, S. & Rodr\u00edguez-Prieto, M. \u00c1. A case of contact dermatitis caused by timolol in anti-glaucoma eyedrops. Contact Dermatitis 73(4), 256\u2013257. https:\/\/doi.org\/10.1111\/cod.12435 (2015).","journal-title":"Contact Dermatitis"},{"key":"97565_CR23","doi-asserted-by":"publisher","first-page":"810","DOI":"10.12688\/f1000research.13499.1","volume":"7","author":"SF Martin","year":"2018","unstructured":"Martin, S. F., Rustemeyer, T. & Thyssen, J. P. Recent advances in understanding and managing contact dermatitis. F1000Research 7, 810 (2018).","journal-title":"F1000Research"},{"issue":"3","key":"97565_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.clindermatol.2011.08.019","volume":"30","author":"E Proksch","year":"2012","unstructured":"Proksch, E. & Brasch, J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin. Dermatol. 30(3), 335\u2013344. https:\/\/doi.org\/10.1016\/j.clindermatol.2011.08.019 (2012).","journal-title":"Clin. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97565-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:38:51Z","timestamp":1670081931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-97565-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["97565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-97565-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17896"}}